Closure can boost treatment uptake

A peer‑reviewed Canadian study found that when one supervised consumption site closed (Red Deer) relative to a similar city that kept one open (Lethbridge), there was no detectable rise in deaths but there was a marked increase in clients starting opioid agonist therapy and a modest rise in overnight non‑emergency hospitalizations. The authors note limited statistical power on mortality but highlight that closure was associated with shifts toward formal treatment. — If true more broadly, the idea reframes SCS policy tradeoffs: sites may reduce immediate public use harms but also could reduce incentives or pathways into medication‑assisted treatment, so policy should weigh treatment linkage as a central metric.